Biological characteristics of γδT cells and application in tumor immunotherapy

被引：6
|
作者：
Zhu, Renhong [1 ,2 ]
Yan, Qian [3 ]
Wang, Yashu [4 ]
Wang, Keqiang [1 ]
机构：
[1] Shandong First Med Univ, Dept Lab Med, Affiliated Hosp 2, Tai An, Peoples R China
[2] Taian Tumor Prevent & Treatment Hosp, Dept Lab Med, Tai An, Peoples R China
[3] Second Hosp Tradit Chinese Med, Dept Lab Med, Tai An, Peoples R China
[4] Qingdao Univ, Dept Lab Med, Affiliated Taian City Cent Hosp, Tai An, Peoples R China
来源：
FRONTIERS IN GENETICS | 2023年 / 13卷
基金：
中国国家自然科学基金;
关键词：
gamma delta T cells; tumor; immunotherapy; progress; biological; BISPHOSPHONATE ZOLEDRONIC ACID; HUMAN NATURAL-KILLER; STEM-LIKE CELLS; ALPHA-BETA; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; HEPATOCELLULAR-CARCINOMA; CELLULAR IMMUNOTHERAPY; CHEMOTHERAPY IMPROVES; DENDRITIC CELLS;
D O I：
10.3389/fgene.2022.1077419
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Human gamma delta T cells are a special immune cell type which exist in small quantities in the body, do not require processing and presentation for antigen recognition, and have non-major histocompatibility complex (MHC)-restricted immune response. They play an important role in the body's anti-tumor, anti-infection, immune regulation, immune surveillance and maintenance of immune tolerance. This article reviews the generation and development of human gamma delta T cells, genetic characteristics, classification, recognition and role of antigens, and research progress in tumor immunotherapy.
引用
收藏
页数：14
相关论文
共 50 条
  • [41] Regulatory T cells in the immunotherapy of melanoma
    Ouyang, Zhengxiao
    Wu, Hongwei
    Li, Linqin
    Luo, Yi
    Li, Xianan
    Huang, Gang
    TUMOR BIOLOGY, 2016, 37 (01) : 77 - 85
  • [42] The application of nanoparticles in immunotherapy for hepatocellular carcinoma
    Hu, Xinyao
    Zhu, Hua
    He, Xiaoqin
    Chen, Jiayu
    Xiong, Lin
    Shen, Yang
    Li, Jiayi
    Xu, Yangtao
    Chen, Wenliang
    Liu, Xin
    Cao, Dedong
    Xu, Ximing
    JOURNAL OF CONTROLLED RELEASE, 2023, 355 : 85 - 108
  • [43] γδ T cells:: A new frontier for immunotherapy?
    Lamb, LS
    Lopez, RD
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (03) : 161 - 168
  • [44] Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy
    Liu, Xia
    Hoft, Daniel F.
    Peng, Guangyong
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (03) : 1073 - 1083
  • [45] Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application
    Miyashita, Masatsugu
    Shimizu, Teruki
    Ashihara, Eishi
    Ukimura, Osamu
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (16)
  • [46] PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?
    Simon, Sylvain
    Labarriere, Nathalie
    ONCOIMMUNOLOGY, 2018, 7 (01):
  • [47] Immunotherapy with regulatory T cells in transplantation
    Peters, J. H.
    Koenen, H. J. P. M.
    Hilbrands, L. B.
    Joosten, I.
    IMMUNOTHERAPY, 2009, 1 (05) : 855 - 871
  • [48] Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity
    Muto, Masato
    Baghdadi, Muhammad
    Maekawa, Ryuji
    Wada, Haruka
    Seino, Ken-ichiro
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (08) : 941 - 949
  • [49] Application of Natural Killer T-Cells to Posttransplantation Immunotherapy
    Shin-ichiro Fujii
    International Journal of Hematology, 2005, 81 : 1 - 5
  • [50] Regulatory T cells in cancer immunotherapy
    Tanaka, Atsushi
    Sakaguchi, Shimon
    CELL RESEARCH, 2017, 27 (01) : 109 - 118
12345